carmustine has been researched along with Cystadenocarcinoma in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Facchini, V | 1 |
| Gadducci, A | 1 |
| Bogi, G | 1 |
| Colombi, L | 1 |
| Basile, AG | 1 |
| Ballantini, M | 1 |
| De Pasquale, F | 1 |
| Fioretti, P | 1 |
| Godfrey, TE | 1 |
| King, A | 1 |
| Rentschler, R | 1 |
2 other studies available for carmustine and Cystadenocarcinoma
| Article | Year |
|---|---|
Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; | 1985 |
1,3-Bis (2-chloroethyl)-1-nitrosourea: effects on advanced ovarian carcinoma.
Topics: Adult; Aged; Blood Platelets; Carmustine; Cystadenocarcinoma; Drug Resistance; Female; Humans; Leuko | 1973 |